Core Viewpoint - China Heart Heart Fertilizer (01866) has seen a significant stock price increase, reaching a new historical high, driven by geopolitical tensions affecting global urea and methanol supply [2] Group 1: Stock Performance - China Heart Heart Fertilizer's stock rose over 7%, peaking at 10.97 HKD, and is currently trading at 10.84 HKD with a trading volume of 26.1 million HKD [2] - The stock has shown a daily increase of 6.07% [2] Group 2: Market Context - Iranian officials have declared a state of full alert, which may disrupt natural gas supplies, impacting global urea and methanol availability [2] - The potential for a localized shortage in urea and methanol could benefit domestic producers with significant production capacity and high dividend yields [2] Group 3: Company Actions - China Heart Heart Fertilizer has been actively repurchasing shares, spending approximately 8.84 million HKD to buy back 874,000 shares on January 23 [2] - The company announced a share repurchase plan on January 12, intending to buy back up to 10% of its issued shares for a total cost not exceeding 200 million HKD within the year [2]

智通财经APP讯，医渡科技(02158)公布，2026年1月27日耗资约227万港元回购37.86万股股份。 ...

十月稻田(09676)发布公告，于2026年1月27日该公司斥资357.65万港元回购39万股股份，回购价格为每 股9.03-9.28港元。 ...

证券日报网讯 1月27日，涪陵榨菜（002507）在互动平台回答投资者提问时表示，二级市场股价波动受 多重因素影响，公司坚持做好主业，以长期、稳中有升的分红规划回报投资者，回购事项需综合多方因 素而定，若有相关计划公司将按相关规定及时公告。 ...

截至2026年1月27日，公司本次股份回购方案累计通过上海证券交易所交易系统以集中竞价交易方式回 购股份907.37万股，已回购股份占公司总股本的比例为0.14%，购买的最高价为人民币70.00元/股，最低 价为人民币57.20元/股，已支付的总金额为人民币6.05亿元(不含交易费用)。 智通财经APP讯，恒瑞医药(01276)发布公告，江苏恒瑞医药股份有限公司(以下简称"公司")于2025年8 月20日召开第九届董事会第十八次会议审议通过了《关于以集中竞价交易方式回购公司A股股份方案的 议案》，同意公司使用自有资金，以集中竞价交易方式回购公司股份用于实施A股员工持股计划。回购 价格不超过人民币90.85元/股(含)，回购资金总额不低于人民币10亿元且不超过20亿元。回购期限为自 董事会审议通过回购股份方案之日起12个月以内。 2026年1月，公司通过上海证券交易所交易系统以集中竞价交易方式回购股份17.5万股，已回购股份占 公司总股本的比例为0.003%，购买的最高价为人民币57.48元/股，最低价为人民币57.20元/股，已支付 的总金额为人民币1003.86万元(不含交易费用)。 ...

2026年1月，公司通过上海证券交易所交易系统以集中竞价交易方式回购股份17.5万股，已回购股份占 公司总股本的比例为0.003%，购买的最高价为人民币57.48元/股，最低价为人民币57.20元/股，已支付 的总金额为人民币1003.86万元(不含交易费用)。 恒瑞医药（600276）(01276)发布公告，江苏恒瑞医药股份有限公司(以下简称"公司")于2025年8月20日 召开第九届董事会第十八次会议审议通过了《关于以集中竞价交易方式回购公司A股股份方案的议 案》，同意公司使用自有资金，以集中竞价交易方式回购公司股份用于实施A股员工持股计划。回购价 格不超过人民币90.85元/股(含)，回购资金总额不低于人民币10亿元且不超过20亿元。回购期限为自董 事会审议通过回购股份方案之日起12个月以内。 截至2026年1月27日，公司本次股份回购方案累计通过上海证券交易所交易系统以集中竞价交易方式回 购股份907.37万股，已回购股份占公司总股本的比例为0.14%，购买的最高价为人民币70.00元/股，最低 价为人民币57.20元/股，已支付的总金额为人民币6.05亿元(不含交易费用)。 ...

（记者 王晓波） 每经AI快讯，兴发集团1月27日晚间发布公告称，2026年1月27日，公司通过集中竞价交易方式首次回 购股份数量约为157万股，占公司总股本的比例为0.14%，回购成交的最高价为42.05元/股，最低价为 41.6元/股，支付的资金总额为人民币6554.25万元。 每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 ...

Core Viewpoint - Elis has disclosed the purchase of its own shares from January 19 to January 23, 2026, as part of its share buyback program authorized by the General Shareholders' Meeting [2][3]. Summary by Relevant Sections Share Buyback Details - The total number of shares acquired during the buyback period is 505,794 shares, with a weighted average price of €23.8800 [3]. - The purchases were made across various platforms, including XPAR, DXE, TQE, and AQE, on different dates within the specified period [2]. Purpose of Share Purchases - The primary purposes of the share buyback operations are to cover maturing performance share plans, allocate free shares to employees as part of the Elis for All 2026 international employee shareholding plan, and fulfill obligations related to the delivery of treasury shares under the potential conversion of Bonds Convertible into New Shares and/or Exchangeable for Existing Shares (OCEANEs) due September 22, 2029 [3]. - Any remaining shares after fulfilling these obligations are intended to be canceled in accordance with the resolution from the Combined General Meeting held on May 22, 2025 [3].

Group 1 - The core viewpoint of the news is that Shunfa Hengneng (SZ000631) has reached its daily limit with a price of 4.35 yuan, reflecting a 10.13% increase and a total market capitalization of 10.419 billion yuan [1] - The company is undergoing a significant business transformation from traditional real estate to the clean energy sector, with multiple initiatives being implemented simultaneously [2] - A large share repurchase plan of 250 to 500 million yuan is in place, which is expected to enhance per-share equity and demonstrate the company's confidence in its future development [2] Group 2 - The company has received a government subsidy of 26.5 million yuan, which accounts for 31.22% of its projected net profit for 2024, strengthening its financial capacity in the renewable energy sector [2] - The upgrade of wind farms is expected to increase installed capacity from 22.5 MW to 90 MW, leading to an anticipated 3.5-fold increase in annual electricity generation [2] - The clean energy industry is currently receiving strong policy support, and market attention towards clean energy companies is increasing, aligning with the company's transformation direction [2]

Core Viewpoint - Macquarie's report indicates that Pop Mart's Valentine's Day limited edition blind box series has been well-received, with the first batch selling out quickly. The firm believes that Pop Mart's diverse product and IP portfolio will continue to drive consumer engagement and revenue growth, projecting that the contribution of its top two to six IPs to revenue will increase from 43% in 2025 to 48.6% this year [1]. Group 1 - The first batch of Pop Mart's Valentine's Day limited edition blind box series sold out rapidly, indicating strong consumer demand [1]. - Macquarie expects the revenue contribution from Pop Mart's top IPs to rise from 43% in 2025 to 48.6% in the current year, reflecting the company's effective product development and consumer interaction strategies [1]. - Recent stock price adjustments are attributed to investor concerns over the slowdown in Pop Mart's U.S. market operations, which Macquarie believes is an overreaction [1]. Group 2 - Macquarie maintains a "Outperform" rating for Pop Mart, with a target price of 470 HKD, citing optimism about production capacity expansion supporting sales growth [2]. - Citigroup has reiterated a "Buy" rating for Pop Mart, highlighting confidence in new product launches and share buybacks [2].